Pathologic Complete Response of HER-2 Neu-Positive Invasive Ductal Carcinoma and Ductal CarcinomaIn Situfollowing Neoadjuvant Chemotherapy plus Trastuzumab: A Case Report and Review of Literature-Reference-Cited by-同舟云学术

Pathologic Complete Response of HER-2 Neu-Positive Invasive Ductal Carcinoma and Ductal CarcinomaIn Situfollowing Neoadjuvant Chemotherapy plus Trastuzumab: A Case Report and Review of Literature

Published:2012 Issue: Volume:2012 Page:1-6
ISSN:2090-6900
Container-title:Case Reports in Surgery
language:en
Short-container-title:Case Reports in Surgery

Author:

Gunia Sommer R.¹^ORCID,Patel Mita S.²³,Mamounas Eleftherios P.³⁴

Affiliation:

1. Department of Surgery, Affinity Medical Center, Massillon, OH 44646, USA

2. Department of Surgery, Akron General Medical Center, Akron, OH 44307, USA

3. Cancer Center, Aultman Health Foundation, Canton, OH 44710, USA

4. Northeastern Ohio Universities College of Medicine, Rootstown, OH 44272, USA

Publisher

Hindawi Limited

Subject

General Earth and Planetary Sciences,Water Science and Technology,Geography, Planning and Development

Link

http://downloads.hindawi.com/journals/cris/2012/454273.pdf

Reference19 articles.

1. Neoadjuvant Chemotherapy for Operable Breast Cancer: Is This the Future?

2. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer.

3. Sequential Preoperative or Postoperative Docetaxel Added to Preoperative Doxorubicin Plus Cyclophosphamide for Operable Breast Cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-27

4. Preoperative Chemotherapy: Updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27

5. Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohort

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of HER2-directed targeted therapy on HER2-positive DCIS of the breast;Reports of Practical Oncology and Radiotherapy;2021-04-14

2. Increased Malignant Microcalcifications after Neoadjuvant Chemotherapy in Advanced Breast Cancer;Journal of Breast Cancer;2016